DIAGNOSTIC HYBRIDS INC

Diagnostic Hybrids Inc. specializes in advanced chemical manufacturing and process development within the specialty chemical sector, leveraging its facility in Athens, Ohio, to support industrial and government-aligned production needs. The company’s core capabilities center on the synthesis of high-purity chemical compounds, precision formulation, and scalable batch processing, with technical expertise in reaction engineering, process optimization, and quality control systems compliant with industrial and regulatory standards. While specific contract details are not available, its NAICS classification of 325413 indicates a focus on manufacturing pharmaceutical preparations and related specialty chemicals, suggesting capabilities in controlled substance handling, GMP-aligned production workflows, and analytical validation. The firm’s operational model emphasizes reproducibility, contamination control, and supply chain integrity—key differentiators for mission-critical applications requiring consistent material output. No award history is available to identify specific federal agencies or programmatic relationships, so no direct agency experience can be confirmed. Similarly, without recent contract data, there is no verifiable pattern of engagement with government entities. The company’s primary industry focus is the specialty chemical manufacturing vertical, as defined by NAICS 325413, which encompasses the production of chemical products for medical, scientific, or technical use. This includes formulation of active pharmaceutical ingredients, diagnostic reagents, or precision chemical intermediates, positioning the firm as a niche supplier for research, defense, or public health applications requiring high-specification chemical outputs. Diagnostic Hybrids Inc. operates as a small business under the 2L entity structure, with no public certifications on file. Its geographic presence is limited to its Athens, Ohio facility, indicating a localized but technically focused footprint within the federal supply chain for specialty chemical production. The company’s market positioning is defined by its capacity for small-batch, high-precision manufacturing rather than large-scale commodity output.